IRRITABLE BOWEL SYNDROME-SPECIFIC MICROBIAL BIOMARKER, AND METHOD FOR PREDICTING RISK OF IRRITABLE BOWEL SYNDROME BY USING SAME

The present invention provides a biomarker for the diagnosis or risk prediction of irritable bowel syndrome (IBS), and a method for the diagnosis or risk prediction of IBS by using the biomarker. In addition, the present invention provides a composition for detecting the biomarker, and a kit for dia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OH, Hyeonseok, KIM, Namil, MIN, Uigi
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides a biomarker for the diagnosis or risk prediction of irritable bowel syndrome (IBS), and a method for the diagnosis or risk prediction of IBS by using the biomarker. In addition, the present invention provides a composition for detecting the biomarker, and a kit for diagnosis or risk prediction of irritable bowel syndrome, comprising the composition. The biomarker provided in the present invention identifies intestinal microorganisms at the genus or species level, thereby enabling more accurate diagnosis or risk prediction of irritable bowel syndrome. La présente invention concerne un biomarqueur pour le diagnostic ou la prédiction de risque du syndrome de l'intestin irritable (SII), et un procédé pour le diagnostic ou la prédiction de risque du syndrome de l'intestin irritable à l'aide du biomarqueur. De plus, la présente invention concerne une composition pour détecter le biomarqueur, et un kit pour le diagnostic ou la prédiction de risque du syndrome de l'intestin irritable, comprenant la composition. Le biomarqueur selon la présente invention identifie des micro-organismes intestinaux au niveau du genre ou de l'espèce, permettant ainsi un diagnostic plus précis ou une prédiction de risque du syndrome du côlon irritable. 본 발명은 과민성 대장증후군(IBS)의 진단 또는 위험도 예측을 위한 바이오마커 및 상기 바이오마커를 이용한 IBS의 진단 또는 위험도 예측 방법을 제공한다. 또한 본 발명은 상기 바이오마커를 탐지하기 위한 조성물 및 상기 조성물을 포함하는 과민성 대장증후군의 진단 또는 위험도 예측용 키트를 제공한다. 본 발명이 제공하는 바이오마커는 장내 미생물을 속 또는 종 수준에서 동정함으로써 보다 정확도 높은 과민성 대장증후군의 진단 및 위험도 예측이 가능하다.